相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research
Eleonora Spekker et al.
BIOMEDICINES (2022)
Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls
Sola Adeleke et al.
PERSONALIZED MEDICINE (2022)
The Role of Alpha Oscillations among the Main Neuropsychiatric Disorders in the Adult and Developing Human Brain: Evidence from the Last 10 Years of Research
Giuseppe Ippolito et al.
BIOMEDICINES (2022)
Accuracy of EEG Biomarkers in the Detection of Clinical Outcome in Disorders of Consciousness after Severe Acquired Brain Injury: Preliminary Results of a Pilot Study Using a Machine Learning Approach
Francesco Di Gregorio et al.
BIOMEDICINES (2022)
Surgery for T4 Colorectal Cancer in Older Patients: Determinants of Outcomes
Michael Osseis et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Frequency and coexistence of KRAS, NRAS, BRAF and PIK3CA mutations and occurrence of MMR deficiency in Danish colorectal cancer patients
Tim Svenstrup Poulsen et al.
APMIS (2021)
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer
M. Michl et al.
VIRCHOWS ARCHIV (2021)
Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives
Svetlana N. Aleksakhina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Leah H. Biller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database
Johannes Uhlig et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China
Xiao-na Chang et al.
CURRENT MEDICAL SCIENCE (2021)
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan
Tatsuki Ikoma et al.
BMC CANCER (2021)
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
Wei Cao et al.
CHINESE MEDICAL JOURNAL (2021)
Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response
Piero Boraschi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2021)
Don't Hurt Me No More: State-dependent Transcranial Magnetic Stimulation for the treatment of specific phobia
Sara Borgomaneri et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
BRAFV600E mutant colorectal cancer cells mediate local immunosuppressive microenvironment through exosomal long noncoding RNAs
Jie Zhi et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia
Amjad Alharbi et al.
PLOS ONE (2021)
The Spectrum, Tendency and Predictive Value of PIK3CA Mutation in Chinese Colorectal Cancer Patients
Xinhui Fu et al.
FRONTIERS IN ONCOLOGY (2021)
Editorial of Special Issue Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
Masaru Tanaka et al.
BIOMEDICINES (2021)
Memories are not written in stone: Re-writing fear memories by means of non-invasive brain stimulation and optogenetic manipulations
Sara Borgomaneri et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Clinical Features, Molecular Alterations and Prognosis of Colorectal Adenocarcinoma With Mucinous Component in Chinese Patients
Xiaoli Jia et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2021)
Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients
Ye Yuan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2021)
Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer
Huashan Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran
Abolfazi Yari et al.
JOURNAL OF GASTROINTESTINAL CANCER (2021)
Clinicopathological characteristics and mutational profile of KRAS and NRAS in
Donia Ounissi et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2021)
Role and molecular mechanism of stem cells in colorectal cancer initiation
Meng-Yan Wang et al.
JOURNAL OF DRUG TARGETING (2020)
PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis
Juan Jin et al.
ACTA ONCOLOGICA (2020)
Brain malignancies: Glioblastoma and brain metastases
Tamara T. Lah et al.
SEMINARS IN CANCER BIOLOGY (2020)
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives
E. Martinelli et al.
ANNALS OF ONCOLOGY (2020)
RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer
To Van Ta et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China
Xiangyan Zhang et al.
PEERJ (2020)
Effect of Tumor Location on Clinicopathological and Molecular Markers in Colorectal Cancer in Eastern China Patients: An Analysis of 2,356 Cases
Yaolin Song et al.
FRONTIERS IN GENETICS (2020)
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
Jozsef Timar et al.
CANCER AND METASTASIS REVIEWS (2020)
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia et al.
CANCER TREATMENT REVIEWS (2020)
KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study
Hector Eduardo Sanchez-Ibarra et al.
PLOS ONE (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population
Ya-Sian Chang et al.
CANCER MEDICINE (2019)
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer
Sorbarikor Piawah et al.
CANCER (2019)
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution
Khurum Khan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
Brain metastases
Achal Singh Achrol et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
The Developing Story of Predictive Biomarkers in Colorectal Cancer
Stergios Boussios et al.
JOURNAL OF PERSONALIZED MEDICINE (2019)
Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer
Luca Reggiani Bonetti et al.
DISEASE MARKERS (2018)
Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients
Yajian Wang et al.
VIRCHOWS ARCHIV (2018)
Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma
Jianhua Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Fang Guo et al.
SCIENTIFIC REPORTS (2018)
Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers
Qiwei Yang et al.
FRONTIERS IN ONCOLOGY (2018)
Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
Yuji Miyamoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers
Britta Kleist et al.
TUMOR BIOLOGY (2017)
Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
David Lok Hang Chan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis
Shih-Ching Chang et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients
Binnur Bagci et al.
CANCER BIOMARKERS (2016)
Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
Vincenzo Sforza et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression
Ya-Ping Ye et al.
ONCOTARGET (2016)
Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern
Humaid O. Al-Shamsi et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Akihito Kawazoe et al.
BMC CANCER (2015)
Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases
Jing Zhang et al.
SCIENTIFIC REPORTS (2015)
B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
Ricarda Herr et al.
CANCER RESEARCH (2015)
BRAF Mutation Predicts for Poor Outcomes After Metastasectomy in Patients With Metastatic Colorectal Cancer
Rona Yaeger et al.
CANCER (2014)
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study
Serban Negru et al.
BMJ OPEN (2014)
Effectors of Epidermal Growth Factor Receptor Pathway: The Genetic Profiling of KRAS, BRAF, PIK3CA, NRAS Mutations in Colorectal Cancer Characteristics and Personalized Medicine
Yinchen Shen et al.
PLOS ONE (2013)
Detection of KRAS Mutations and Their Associations with Clinicopathological Features and Survival in Chinese Colorectal Cancer Patients
Z. Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Combined mutational analysis of KRAS, NRAS and BRAF genes in Indian patients with colorectal carcinoma
Sarita B. Bagadi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2012)
Tracing the Origins of Hakka and Chaoshanese by Mitochondrial DNA Analysis
Wen-Zhi Wang et al.
AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY (2010)
KRAS mutations in Slovene patients with colorectal cancer: frequency, distribution and correlation with the response to treatment
Alenka Licar et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)